药物与临床
LIU Guangjian;WANG Hua;WANG Yunfu;HE Guohou;LUO Guojun;HUANG Chaofen
2007, 26(6): 621-624.
Citalopram in the Treatment of 31 Cases of Depressive Mood Disorder with Headache as the Chief Complaint
LIU Guangjian, WANG Hua, WANG Yunfu , HE Guohou, LUO Guojun, HUANG Chaofen(Department of Medical Neurology, Taihe Hospital Affiliated with the Yunyang Medical College, Shiyan 442000, China)ABSTRACTObjectiveTo compare the therapeutic effectiveness and safeness of citalopram and amitriptyline in the treatment of depressive mood disorder with headache as the chief complaint. Methods91 cases of depressive mood disorder with headache as the chief complaint meeting the criteria of selection were randomly divided into 3 groups: the trial group (n=31), control groups 1(n=30) and 2(n=30).Patients of the trial group, control group 1 and control group 2 were given each 20 mg·d-1 of citalopram, 100-150 mg·d-1 of amitriptyline and epuivalent amount of analgesics PO, respectively, for 6 consecutive weeks. The clinical manifestations in patients of the 3 groups were assessed with the Hamilton Depression Scale(HAMD Scale) before the treatment as well as 1,2,4 and 6 weeks after the beginning of the treatment. Adverse reactions of the drugs were evaluated at the corresponding time points after the beginning of the treatment. ResultsThe rates of clinical improvement in patients of the trial group and control group 1 after the 6 week treatment were 87.1% and 86.7%, respectively. The majority of patients in these 2 groups experienced remission of headache, improvement in sleeping and restoration of living and working capabilities. The rate of clinical improvement in patients of the control group 2 was as low as 26.7%. The HAMD scoring in patients of the trial group was strikingly decreased after 1 to 2 weeks of treatment as compared with that before the treatment(P<0.05). The decrease in the HAMD scoring in patients of the control group 1, however, was not significant after the 1-2 week treatment (P>0.05). The HAMD scorings in patients of the trial group and control group 1 were both significantly decreased after 4 to 6 weeks of treatment (P<0.01), the difference between these 2 groups ,however,being insignificant(P>0.05). Adverse reactions in patients of the trial group were relatively mild and rare as compared with those in patients of the control group 1 but were comparable with those in patients of the control group 2. ConclusionThe effect of citalopram in the treatment of depressive mood disorder with headache as the chief complaint was shown to be comparable with that of amitriptyline. However, citalopram started to act earlier, had greater safeness and fewer adverse reactions.KEY WORDSCitalopram; Amitriptyline; Headache; Mood disorder, depressive